Key facts
- It has raised $250K; the latest was Early Stage VC in Jan 2025.
- Notable investors include Bic Gipuzkoa, Ekin + Program, Mylkcubator Incubation Programme, Nucleus Capital, SantanderX.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Cultzyme
- ·The full record, as it builds
Funding rounds
No funding rounds for Cultzyme are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cultzyme
Developer of intelligent bioreactors and bioprocessors designed for the food, life sciences, and biomaterials industries. The company provides sensors and control systems that interact with artificial intelligence algorithms, optimizing growth conditions to efficiently carry out cell culture and precision fermentation, providing clients with the safety they need to bring their products to market.
- Sector
- Business Products and Services (B2B)
- HQ
- Donostia-San Sebastian, Spain
- Founded
- 2022
- Employees
- 8
- Website
- cultzyme.com/
- Ownership
- Privately Held (backing)
Cultzyme doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cultzyme shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cultzyme in its N-PORT filings yet. We sweep new filings monthly.